Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -789,608 | -555,625 | -335,643 | -263,507 | -166,783 |
| Depreciation Amortization | 17,434 | 17,158 | 13,538 | 9,648 | 7,419 |
| Accounts payable and accrued liabilities | 23,600 | 3,614 | 526 | 6,658 | 2,541 |
| Other Working Capital | 46,117 | -24,714 | -12,694 | 18,956 | 15,958 |
| Other Operating Activity | 138,073 | 146,141 | 53,720 | 38,598 | 42,436 |
| Operating Cash Flow | $-564,384 | $-413,426 | $-280,553 | $-189,647 | $-98,429 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 584,059 | -623,698 | -254,388 | 95,139 | -555,996 |
| PPE Investments | -71,028 | -55,737 | -62,242 | -28,029 | -7,055 |
| Purchase Sale Intangibles | -5,224 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -5,224 | 0 | 0 | 0 | -8,816 |
| Investing Cash Flow | $507,807 | $-679,435 | $-316,630 | $67,110 | $-571,867 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,017 | -574 | 0 | 0 |
| Common Stock Issued | 21,187 | 681,127 | 1,039,801 | 241,896 | 487,173 |
| Other Financing Activity | 0 | 57,582 | 36,947 | -362 | -453 |
| Financing Cash Flow | $21,187 | $737,692 | $1,076,174 | $241,534 | $486,720 |
| Beginning Cash Position | 417,099 | 772,268 | 293,277 | 174,280 | 347,845 |
| End Cash Position | 381,709 | 417,099 | 772,268 | 293,277 | 164,269 |
| Net Cash Flow | $-35,390 | $-355,169 | $478,991 | $118,997 | $-183,576 |
| Free Cash Flow | |||||
| Operating Cash Flow | -564,384 | -413,426 | -280,553 | -189,647 | -98,429 |
| Capital Expenditure | -71,028 | -55,737 | -62,242 | -28,029 | -7,055 |
| Free Cash Flow | -635,412 | -469,163 | -342,795 | -217,676 | -105,484 |